Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

The Year 2017 in Images

137 views

Published on

My favorite images from articles published in Pharma Marketing News - including Pharma Industry Update & Pharma Marketing Blog - in 2017.

Published in: Health & Medicine
  • Be the first to comment

The Year 2017 in Images

  1. 1. 2017. Pharma Marketing Network. All rights reserved. The Year 2017 in Images TM
  2. 2. 2017. Pharma Marketing Network. All rights reserved. “I Literally Learned from This Guy,” Says Shkreli In a controversial move, Marathon Pharmaceuticals is charging $89,000 a year for a decades-old Duchenne drug that was approved by US regulators in February, 2017. The infamous “pharma bro,” who gained notoriety after buying an older drug and raising the price by 5,000 percent — and then taunting critics on social media — recently praised Ovation, which Aronin ran, on his web site. “These guys invented price increases,” he wrote. “I literally learned it from them.” http://sco.lt/50R1yT
  3. 3. 2017. Pharma Marketing Network. All rights reserved. Allergan CEO Says Martin Shkreli is a "Mentor" Sarah Hassan was new to the hedge fund world in 2010 when a longtime friend of her father suggested she meet a “rising star” in the industry: Martin Shkreli. The friend, Brent Saunders, the chief executive of pharmaceutical giant Allergan, said he had had “some phenomenal returns” by investing in one of Shkreli’s funds, Hassan told a federal jury. “Mr. Saunders had suggested we meet up because I was trying to learn about the hedge fund world. He thought Martin could be mentor,” she said. http://sco.lt/4iGheL
  4. 4. 2017. Pharma Marketing Network. All rights reserved. Trump Will "Make Pharma Great Again!" Martin Shkreli, better known throughout the world as “Pharma Bro,” is betting on Donald Trump to bring pharmaceutical jobs back to the U.S. “Donald Trump is a dream for business people like me,” Shkreli said during an exclusive interview with FOX Business Network’s Maria Bartiromo. “I think Trump’s going to make pharma great again.” http://sco.lt/5algcj
  5. 5. 2017. Pharma Marketing Network. All rights reserved. “They’re Getting Away with Murder!” President Trump has talked about giving drug companies a big tax break if they bring their wealth back to US shores. But last time they got such a tax break, it didn’t pan out that way. Instead, drug makers used the tens of billions they brought back to the US in the mid-2000s to enrich their CEOs and drive up their stock prices. They also laid off thousands of workers. http://sco.lt/6HIA9x
  6. 6. 2017. Pharma Marketing Network. All rights reserved. PhRMA Ousts Bad Egg Members to Appease Trump This is supposed to be “PhRMA's way of trying to get rid of smaller companies that engage in the controversial practice of buying older drugs and jacking up the prices.” But PhRMA knew that some of these companies gouged prices when they accepted them as members (read, for example, “PhRMA Accepts Price Gouging #Pharma Companies Into Its Tent”; http://sco.lt/5a8tNJ and “Big #Pharma Should Secede From PhRMA, Says @John_LaMattina”; http://sco.lt/8UQ2vh).
  7. 7. 2017. Pharma Marketing Network. All rights reserved. Trump Lets Pharma "Get Away With Murder!" In the early days of his administration, President Trump did not hesitate to bash the drug industry. But a draft of an executive order on drug prices appears to give the pharmaceutical industry much of what it has asked for — and no guarantee that costs to consumers will drop. But the proposed order does little to specifically call out the drug industry and instead focuses on rolling back regulations, a favorite target of the administration across many federal agencies. http://sco.lt/5lcuKf
  8. 8. 2017. Pharma Marketing Network. All rights reserved. PhRMA Dumps Lots More Money Into Coffers of Pols & Patients Facing bipartisan hostility over high drug prices in an election year, the pharma industry’s biggest trade group boosted revenue by nearly a fourth last year and spread the millions collected among hundreds of lobbyists, politicians and patient groups. Only a handful of 7,685 health advocacy groups in the U.S. are completely independent of pharmaceutical industry money, according PharmedOut. http://sco.lt/9KWYcb and http://sco.lt/786qbB
  9. 9. 2017. Pharma Marketing Network. All rights reserved. Regeneron CEO vs. Allergan “Chief” “It’s nuts,” Schleifer said of Allergan’s controversial move to protect patents by transferring them to a Native American tribe. His remarks were made at the annual Forbes health care conference. http://sco.lt/6HIA9x
  10. 10. 2017. Pharma Marketing Network. All rights reserved. The "Three Stooges of Drug Price Lobbying!". A civil war has broken out among the most powerful players in the pharma- ceutical industry — including brand- name and generic drug makers, and even your local pharmacists — with each blaming others for the rising price of medicine. “You remember that old photograph of the Three Stooges, their faces cracked sideways and they are pointing at each other?” asked Chester Davis Jr., the president of the Association for Accessible Medicines. “Everyone is doing the finger-pointing, when in fact there is a lot of blame to go around.” http://sco.lt/6n4Flp
  11. 11. 2017. Pharma Marketing Network. All rights reserved. Opioids vs. Tobacco: Can a Case Be Made That Likens the Two? A lawsuit in Ohio has compared five of the largest pharma- ceutical manufactures in the country to the tobacco industry, alleging they lied to the public about health risks http://sco.lt/74h44X
  12. 12. 2017. Pharma Marketing Network. All rights reserved. Dancing with Fentanyl According to Huffington Post, "Pharmaceutical sales representatives selling an opioid-based drug 50 times more powerful than heroin filmed a company-made rap video in which they danced with a giant bottle of their deadly fentanyl spray, a federal grand jury alleged in an indictment unsealed in October, 2017. You can’t make this stuff up! http://sco.lt/9JOA6L
  13. 13. 2017. Pharma Marketing Network. All rights reserved. Merck CEO Frazier Quits Trump Advisory Council The head of U.S. drugmaker Merck & Co. has resigned from a manufacturing advisory council to the Trump admin- istration in an apparent protest of the president’s failure to condemn in stronger terms the white supremacists who marched and waged violence in Charlottesville, Va. “As CEO of Merck and as a matter of personal conscience, I feel a responsibility to take a stand against intolerance and extremism,” Mr. Frazier said in the statement. http://sco.lt/6HIA9x
  14. 14. 2017. Pharma Marketing Network. All rights reserved. Trump Administration vs Opioid Epidemic Two days later... Just two days after a top White House official said the United States has the resources it to address the opioid problem without declaring a state of emergency, President Donald Trump now says the deadly opioid epidemic is indeed a national emergency.
  15. 15. 2017. Pharma Marketing Network. All rights reserved. Enough Blame to Go Around for Opioid Epidemic A Long Island doctor is using a novel defense against federal prosecutors accusing him of overprescribing opioid painkillers: He’s blaming the drug manufacturers. In a motion pending in the Eastern District, Dr. Michael Belfiore argued that the multiple counts against him of illegally distributing oxycodone should be dropped, and that the “true culprits in the creation of the opioid epidemic, to wit: Big Pharma” should be held responsible. http://sco.lt/6HIA9x
  16. 16. 2017. Pharma Marketing Network. All rights reserved. Pharma Overuses the Letter Z When Naming Drugs Pharma companies do love to name their drugs using rather uncommon letters. They like to both start their drug names with these letters and mix them throughout the name. Pharma especially seems to love Z. For the drug names considered in this study, the letter Z accounts for 2.52% of all letters used. That's roughly 3,300% different than what would be expected (0.07%). http://sco.lt/8L1BFR
  17. 17. 2017. Pharma Marketing Network. All rights reserved. Pharma Gets Drug Names from Octavia Spencer’s Phone Contact List A March 4, 2017, SNL sketch puts forth a unified theory of drug names, articulated by episode host and 2017 Oscar nominee Octavia Spencer, for Hidden Figures. The setting: An arbitration hearing in a claim against Merck, for stealing the Spencer character’s “intellectual property.” How? The company “named dozens of drugs after members of my family,” she claims. “They’re just flipping through the contacts in my phone.” http://sco.lt/8jQ5rN
  18. 18. 2017. Pharma Marketing Network. All rights reserved. Gilead to Baby Boomers: Yo! Get Off Your Butts! LOL! The ad shows baby boomers lounging on bent trees and wandering aimless through the landscape as if they are in a trance and have nothing better to do! No doubt millennials are in charge of the storyboards for these ads and it's their way of getting back at their baby boomer parents! http://sco.lt/98Yumn
  19. 19. 2017. Pharma Marketing Network. All rights reserved. Marketers vs “Fake” Pharma News The lesson of fake news for marketers is that you can't depend upon advertising and traditional media to mold public opinion about your brand. Instead, you must work get your customers to share the positive truths about your company. Meanwhile make sure, as far as possible, that "fake news" about your company dies on the social media vine. http://sco.lt/7kVml7
  20. 20. 2017. Pharma Marketing Network. All rights reserved. Allergan’s “Fake” Side-by-Side Ads Mislead Sometimes side-by-side images in drug ads are misleading because they claim to be “unretouched photos” whereas they were clearly the same image but one was digitally altered as in the case of a 2016 Kybella ad. This ad for Rhofade, however, says “Illustration only,” which means this is not a real case study of a real person’s response to the drug. http://bit.ly/2vi7lAt
  21. 21. 2017. Pharma Marketing Network. All rights reserved. FDA May Focus Less on Compliance When Reviewing Digital Apps from Silicon Valley
  22. 22. 2017. Pharma Marketing Network. All rights reserved. How Much Risk Information is "Just Right" for TV Drug Ads? FDA's Center for Drug Evaluation and Research (CDER) is exploring the usefulness of limiting the risks in the major statement for most DTC broadcast advertisements for prescription drugs to those that are severe (life-threatening), serious, or actionable, coupled with a disclosure to alert consumers that there are other product risks not included in the advertisement. http://sco.lt/9Dcq6z
  23. 23. 2017. Pharma Marketing Network. All rights reserved. Will Amazon “Crush” Big Pharma? Amazon's unrelenting drive to take over the world continues. The latest potential target of the online retailer's ambitions: prescription drugs. According to reports, Amazon is exploring entering the retail pharmacy market in the U.S., a $400bn a year business that many believe is ripe for disruption. While a final decision has apparently not yet been made, it's not too early for pharma marketers to start considering the prospect of Amazon entering this huge market. http://sco.lt/6HIA9x
  24. 24. 2017. Pharma Marketing Network. All rights reserved. PharmaGuy Marches for Science From my speech at the Doylestown march: “Defunding science impacts us on a local level whether the issue is the quality of our air and water, fracking, opioid drug abuse, or the heroin epidemic. We need leaders who believe in data and scientific evidence to help solve these problems.” Read the entire speech here: http://sco.lt/78EKVl
  25. 25. 2017. Pharma Marketing Network. All rights reserved. Wishing You a Happy New Year!

×